Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial

Eva Chalas, Joseph P Costantino, D Lawrence Wickerham, Norman Wolmark, George C Lewis, Cynthia Bergman, Carolyn D Runowicz
American Journal of Obstetrics and Gynecology · 2005 · vol. 192(4) , pp. 1230–1237 · doi:10.1016/j.ajog.2004.12.083 · PMID:15846210 · W2011246022
article OA: closed CC0 ⤵ 15 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper reports on the prevalence of benign gynecologic conditions observed in women participating in the Breast Cancer Prevention Trial.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Antineoplastic Agents, Hormonal Breast Neoplasms Genital Diseases, Female Genital Diseases, Female Neoplasm Recurrence, Local Tamoxifen Adult Aged Age Distribution Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Breast Neoplasms Breast Neoplasms Chemotherapy, Adjuvant Confidence Intervals Dose-Response Relationship, Drug Female Genital Diseases, Female Genital Diseases, Female Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (22)

Cited by (15)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:41.664291+00:00
License: CC0 · commercial use OK